People are overdosing on injectable weight-loss drugs, FDA warns
Some people are overdosing from certain products marketed for weight loss, federal health officials are warning.
The FDA has received reports of dosing errors involving compounded semaglutide injectable products dispensed in multiple-dose vials, resulting in patients seeking medical attention or requiring hospitalization, the agency stated.
Dosing errors came as a result of people measuring and self-administering incorrect amounts, and health care providers miscalculating doses of the cheaper, compounded versions of weight-loss drugs like Wegovy, the agency said Friday in an alert.
higher risk to patients than those approved by the FDA, and should only be used when a person’s medical needs can’t be met by an available FDA-approved drug, the agency stated in its alert.
Kate Gibson
Source: cbsnews.com